Gordon Bethwaite has worked in the eye care industry for over 25 years, and has held senior leadership roles in both early commercial stage start-ups and global organizations. He has deep knowledge of the market, having worked on several gold-standard technologies, and recently participated in a successful exit with Tear Film Innovations, a dry eye treatment device company, which was acquired by Alcon in 2018. Gordon is currently CEO of Vitranu, a pre-clinical stage company based in Columbus Ohio developing an innovative drug delivery technology to treat eye diseases such as macular degeneration.